ACM
PGEN icon

AlphaCrest Capital Management’s Precigen PGEN Stock Holding History

AlphaCrest Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-93,575
Closed -$467K – 1426
2021
Q3 		$467K Buy
+93,575
New +$539K 0.02% 946

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCrest Capital Management's PGEN Position: Q4 2021 in Review

AlphaCrest Capital Management sold out of Precigen (PGEN) in Q4 2021, closing a stake of 93,575 shares — an estimated $467K sold.

AlphaCrest Capital Management first reported a position in PGEN in Q3 2021 and held it in 1 quarter. The position peaked at $467K in Q3 2021. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

  • AlphaCrest Capital Management reported no remaining Precigen position as of Q4 2021 after selling out during the quarter.
  • AlphaCrest Capital Management sold 93,575 Precigen shares in Q4 2021, an estimated $467K.
  • AlphaCrest Capital Management first reported a position in Precigen in Q3 2021 and held it in 1 quarter.
  • AlphaCrest Capital Management's Precigen position peaked at $467K in Q3 2021.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on AlphaCrest Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.